Publication:
Synthesis, cytotoxicity and QSAR study of N-tosyl-1,2,3,4- tetrahydroisoquinoline derivatives

dc.contributor.authorPingaew R.
dc.contributor.authorWorachartcheewan A.
dc.contributor.authorNantasenamat C.
dc.contributor.authorPrachayasittikul S.
dc.contributor.authorRuchirawat S.
dc.contributor.authorPrachayasittikul V.
dc.date.accessioned2021-04-05T03:32:50Z
dc.date.available2021-04-05T03:32:50Z
dc.date.issued2013
dc.date.issuedBE2556
dc.description.abstract1-Substituted-N-tosyl-1,2,3,4-tetrahydroisoquinoline analogs (4a-4l) were synthesized using the modified Pictet-Spengler reaction and evaluated for cytotoxicity. All tetrahydroisoquinolines displayed cytotoxicity against MOLT-3 cell lines, except for p-methoxy analog 4d. Interestingly, the o-hydroxy derivative 4k was shown to be the most potent cytotoxic against HuCCA-1, A-549 and MOLT-3 cell lines. The lowest IC50 value of 1.23 μM was observed for MOLT-3 cells. Trimethoxy analog 4f exerted the most potent activity against HepG2 with an IC50 of 22.70 μM, which is lower than the reference drug, etoposide. QSAR studies showed that total symmetry index (Gu), 3D-MoRSE (Mor31v and Mor32u) and 3D Petitjean index (PJI3) were the most important descriptors accounting for the observed cytotoxicities. The most potent cytotoxic compound (4k) against MOLT-3 had the highest Gu value, correspondingly the inactive p-methoxy analog (4d) had the lowest Gu value. On the other hand, the highest molecular mass compound (4f) was shown to be the most potent cytotoxic against HepG2 cells. The studies disclose that tetrahydroisoquinolines 4f and 4k are potentially interesting lead pharmacophores that should be further explored. The QSAR models provided insights into the physicochemical properties of the investigated compounds. © 2013 The Pharmaceutical Society of Korea.
dc.format.mimetypeapplication/pdf
dc.identifier.citationArchives of Pharmacal Research. Vol 36, No.9 (2013), p.1066-1077
dc.identifier.doi10.1007/s12272-013-0111-9
dc.identifier.issn2536269
dc.identifier.other2-s2.0-84884209513
dc.identifier.urihttps://hdl.handle.net/20.500.14740/6569
dc.rights.holderScopus
dc.subject.other1,2,3,4 tetrahydro 6,7 dimethoxy 2 [(4 methylphenyl)sulfonyl] 1 (2 hydroxyphenyl)isoquinoline
dc.subject.other1,2,3,4 tetrahydro 6,7 dimethoxy 2 [(4 methylphenyl)sulfonyl] 1 (3 hydroxy 4 methoxyphenyl)isoquinoline
dc.subject.other1,2,3,4 tetrahydro 6,7 dimethoxy 2 [(4 methylphenyl)sulfonyl] 1 (3,4,5 trimethoxyphenyl)isoquinoline
dc.subject.other1,2,3,4 tetrahydro 6,7 dimethoxy 2 [(4 methylphenyl)sulfonyl] 1 (4 bromophenyl)isoquinoline
dc.subject.other1,2,3,4 tetrahydro 6,7 dimethoxy 2 [(4 methylphenyl)sulfonyl] 1 (4 hydroxy 3 methoxyphenyl)isoquinolone
dc.subject.other1,2,3,4 tetrahydro 6,7 dimethoxy 2 [(4 methylphenyl)sulfonyl] 1 (4 hydroxy 3,5 dimethoxyphenyl)isoquinolone
dc.subject.other1,2,3,4 tetrahydro 6,7 dimethoxy 2 [(4 methylphenyl)sulfonyl] 1 (4 hydroxyphenyl)isoquinolone
dc.subject.other1,2,3,4 tetrahydro 6,7 dimethoxy 2 [(4 methylphenyl)sulfonyl] 1 (4 methoxyphenyl)isoquinoline
dc.subject.other1,2,3,4 tetrahydro 6,7 dimethoxy 2 [(4 methylphenyl)sulfonyl] 1 methylisoquinoline
dc.subject.other1,2,3,4 tetrahydro 6,7 dimethoxy 2 [(4 methylphenyl)sulfonyl] 1 ohenylisoquinoline
dc.subject.other1,2,3,4 tetrahydro 6,7 dimethoxy 2 [(4 methylphenyl)sulfonyl]isoquinoline
dc.subject.other1,2,3,4 tetrahydro 6,7 dimethoxy 2 [(4methylphenyl)sulfonyl] 1 (3 pyridyl)isoquinoline
dc.subject.otherDoxorubicin
dc.subject.otherEtoposide
dc.subject.otherN tosyl 1,2,3,4 tetrahydroisoquinoline derivative
dc.subject.otherTetrahydroisoquinoline derivative
dc.subject.otherUnclassified drug
dc.subject.otherArticle
dc.subject.otherBile duct carcinoma
dc.subject.otherCancer cell culture
dc.subject.otherCell strain HepG2
dc.subject.otherControlled study
dc.subject.otherDrug cytotoxicity
dc.subject.otherDrug inhibition
dc.subject.otherDrug synthesis
dc.subject.otherHuman
dc.subject.otherHuman cell
dc.subject.otherHuman cell culture
dc.subject.otherIC 50
dc.subject.otherLiver cell carcinoma
dc.subject.otherLung carcinoma
dc.subject.otherLymphatic leukemia
dc.subject.otherMolecular weight
dc.subject.otherPharmacophore
dc.subject.otherPhysical chemistry
dc.subject.otherPictet Spengler reaction
dc.subject.otherQuantitative structure activity relation
dc.subject.otherAntineoplastic Agents
dc.subject.otherCell Line, Tumor
dc.subject.otherCell Proliferation
dc.subject.otherCell Survival
dc.subject.otherDrug Design
dc.subject.otherDrugs, Investigational
dc.subject.otherHumans
dc.subject.otherHydroxylation
dc.subject.otherInhibitory Concentration 50
dc.subject.otherMagnetic Resonance Spectroscopy
dc.subject.otherMass Spectrometry
dc.subject.otherMolecular Structure
dc.subject.otherNeoplasms
dc.subject.otherPhysicochemical Phenomena
dc.subject.otherQuantitative Structure-Activity Relationship
dc.subject.otherSpectroscopy, Fourier Transform Infrared
dc.subject.otherTetrahydroisoquinolines
dc.subject.otherTosyl Compounds
dc.titleSynthesis, cytotoxicity and QSAR study of N-tosyl-1,2,3,4- tetrahydroisoquinoline derivatives
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84884209513&doi=10.1007%2fs12272-013-0111-9&partnerID=40&md5=aa028d5f7130164b379dd96d7e28b416

Files